NCT03278028 - A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts | Biotech Hunter

Enrollment

159

Participants

Timeline

Start Date

July 13, 2017

Primary Completion Date

March 1, 2018

Study Completion Date

March 1, 2018

Conditions

Common Wart

Interventions

DRUG

A-101 Topical Solution

DRUG

A-101 Vehicle Solution

Trial Locations (16)

14623

Aclaris Investigational Site, Rochester

23507

Aclaris Investigational Site, Norfolk

24501

Aclaris Investigational Site, Lynchburg

27262

Aclaris Investigational Site, High Point

37215

Aclaris Investigational Site, Nashville

37922

Aclaris Investigational Site, Knoxville

68144

Aclaris Investigational Site, Omaha

72916

Aclaris Investigational Site, Fort Smith

77004

Aclaris Investigational Site, Houston

77845

Aclaris Investigational Site, College Station

80210

Aclaris Investigational Site, Denver

84117

Aclaris Investigational Site, Salt Lake City

85308

Aclaris Investigational Site, Glendale

87106

Aclaris Investigational Site, Albuquerque

90045

Aclaris Investigational Site, Los Angeles

92024

Aclaris Investigational Site, Encinitas